Evidence map›Paper›PMID 40258951›Full record

ArticleNature cell biology2025

Tumour interstitial fluid-enriched phosphoethanolamine suppresses T cell function.

Yupeng Wang, Drew Wilfahrt, Patrick Jonker, Konstantinos Lontos, Chufan Cai, Benjamin Cameron, Bingxian Xie, Ronal M Peralta, Emerson R Schoedel, William G Gunn and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hypoxia Impairs CD8Cancers · 2026
    Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Comprehensive Speciation and Computational Study of CuMolecules (Basel, Switzerland) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Yupeng Wang *Tsinghua Medical School, Beijing, China.ORCID http://orcid.org/0009-0009-4217-6569
Drew Wilfahrt *Department of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Patrick JonkerBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Konstantinos LontosDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Chufan CaiBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA.
Benjamin CameronDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Bingxian XieDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Ronal M PeraltaDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.
Emerson R SchoedelDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0009-0004-3841-0555
William G GunnDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0009-0007-9070-7550
Roya AminiTabriziMetabolomics Platform, Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.
Hardik ShahMetabolomics Platform, Comprehensive Cancer Center, University of Chicago, Chicago, IL, USA.ORCID http://orcid.org/0000-0001-8408-5686
Dayana B RivadeneiraDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-9483-7036
Alexander MuirBen May Department for Cancer Research, University of Chicago, Chicago, IL, USA. amuir@uchicago.edu.ORCID http://orcid.org/0000-0003-3811-3054
Greg M DelgoffeDepartment of Immunology, University of Pittsburgh, Pittsburgh, PA, USA. delgoffeg@upmc.edu.ORCID http://orcid.org/0000-0002-2957-8135

Funding

Uncovering the metabolic underpinnings of T cell exhaustionR01AI166598 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELGOFFE, GREG M. · 2022 to 2025
$3.2M
Dissecting the role of hypoxia in T cell differentiation in cancerR01CA277473 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Greg M. Delgoffe, Yana Najjar · 2023 to 2026
$2.4M
Metabolic control of regulatory T cell functional identityR01AI171483 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELGOFFE, GREG M. · 2022 to 2025
$2.4M
Exploring and exploiting metabolic plasticity in regulatory T cellsDP2AI136598 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DELGOFFE, GREG M. · 2017 to 2017
$2.3M
NIAID NIH HHS DP2 AI136598NIAID NIH HHS R01 AI166598NIAID NIH HHS R01 AI171483U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA277473
6 · The paper itself

Abstract

Nutrient stress represents an important barrier for anti-tumour immunity, and tumour interstitial fluid often contains metabolites that hinder immune function. However, it is difficult to isolate the effects of tumour nutrient stress from other suppressive factors. Thus, we used a chemically defined cell culture medium based on the metabolomic profile of tumour interstitial fluid: tumour interstitial fluid medium (TIFM). Culture of CD8

Indexed as

CD8-Positive T-LymphocytesEthanolaminesExtracellular FluidLymphocytes, Tumor-InfiltratingAnimalsCell Line, TumorDiglyceridesFemaleHumansMiceMice, Inbred C57BLReceptors, Antigen, T-CellSignal TransductionTumor MicroenvironmentDiglyceridesEthanolaminesphosphorylethanolamineReceptors, Antigen, T-Cell

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.